Li et al. [54] proposed ITGBL1 as a novel metastasis‐related gene in prostate cancer, and Matsuyama et al. [55] identified ITGBL1 as a promising EMT‐associated biomarker for recurrence prediction in colorectal cancer patients, which might contribute to improved risk stratification. Here, ITGBL1 is linked to prostate cancer.